Record #34860
Efficacy And Safety Of Adalimumab Versus Infliximab In Patients Suffered From Moderate To Severe Active Ulcerative Colitis
Publisher
Original paper date
Jan 3, 2017
Original DOI
Country
Open access
No
Article type
Broad categories
Notes from Retraction Watch
date of retraction unknown, html page overwrite, estimated from notifications;
Citation lifecycle
How this paper is being cited
Pre-retraction
1
Same day
0
Post-retraction
2
% post-retraction
66.7%
~0.2 citations/yr before retraction · ~0.4 citations/yr after
— citing papers
Who is still citing this work
Loading…